UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Neuropsychopharmacology (New York, N.Y.), 2012-04, Vol.37 (5), p.1192-1203

2012

Link zum Volltext

Verfügbarkeit prüfen

Prodrugs of New Psychoactive Substances (NPS): A New Challenge

Journal of forensic sciences, 2020-05, Vol.65 (3), p.913-920

2020

Link zum Volltext

Verfügbarkeit prüfen

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Neuropsychopharmacology (New York, N.Y.), 2013-03, Vol.38 (4), p.552-562

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

European neuropsychopharmacology, 2021-03, Vol.44, p.92-104

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

PloS one, 2016-06, Vol.11 (6), p.e0157021

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Psychopharmacology, 2019-02, Vol.236 (2), p.799-808

2019

Link zum Volltext

Verfügbarkeit prüfen

Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter

International journal of molecular sciences, 2021-11, Vol.22 (23), p.12995

2021

Link zum Volltext

Verfügbarkeit prüfen

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Drug testing and analysis, 2018-02, Vol.10 (2), p.310-322

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

Metabolites, 2024-05, Vol.14 (5), p.270

2024

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration

Drug testing and analysis, 2020-08, Vol.12 (8), p.1144-1153

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones

Drug testing and analysis, 2011-09, Vol.3 (9), p.569-575

2011

Link zum Volltext

Verfügbarkeit prüfen

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Neuropharmacology, 2020-05, Vol.167, p.107933-107933, Article 107933

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry

Analytical chemistry (Washington), 2013-09, Vol.85 (18), p.8535-8542

2013

Link zum Volltext

Verfügbarkeit prüfen

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Current neuropharmacology, 2017-07, Vol.15 (5), p.692-712

2017

Link zum Volltext

Verfügbarkeit prüfen

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

1st ed. 2018., 2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS

Current pharmaceutical biotechnology, 2018, Vol.19 (2), p.144

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity

Metabolites, 2021-08, Vol.11 (8), p.509

2021

Link zum Volltext

Verfügbarkeit prüfen

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

New Psychoactive Substances, 2018-01, p.305-352

2018

Link zum Volltext

Verfügbarkeit prüfen

The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis

Drug testing and analysis, 2016-08, Vol.8 (8), p.875-879

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone

Drug testing and analysis, 2017-03, Vol.9 (3), p.358-368

2017

Link zum Volltext

Verfügbarkeit prüfen

Potential antimalarial derivatives from astraodorol

Archives of Pharmacal Research, 2014, 37(12), , pp.1538-1545

2014

Link zum Volltext

Verfügbarkeit prüfen

Addressing the challenges in forensic drug chemistry II

Drug testing and analysis, 2022-03, Vol.14 (3), p.400-403

2022

Link zum Volltext

Verfügbarkeit prüfen

The new drug phenomenon

Drug testing and analysis, 2014-07, Vol.6 (7-8), p.587-597

2014

Link zum Volltext

Verfügbarkeit prüfen

Test purchase, synthesis and characterization of 3‐fluorophenmetrazine (3‐FPM) and differentiation from its ortho‐ and para‐substituted isomers

Drug testing and analysis, 2017-03, Vol.9 (3), p.369-377

2017

Link zum Volltext

Verfügbarkeit prüfen

Analyses of second-generation 'legal highs' in the UK: Initial findings

Drug testing and analysis, 2010-08, Vol.2 (8), p.377-382

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(284)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Prodrugs of New Psychoactive Substances (NPS): A New Challenge

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration

Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis

Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone

Potential antimalarial derivatives from astraodorol

Addressing the challenges in forensic drug chemistry II

The new drug phenomenon

Test purchase, synthesis and characterization of 3‐fluorophenmetrazine (3‐FPM) and differentiation from its ortho‐ and para‐substituted isomers

Analyses of second-generation 'legal highs' in the UK: Initial findings

Suchergebnisse filtern